Cytovia

Immune Pharmaceuticals to restructure

Tuesday, April 25, 2017

Immune Pharmaceuticals, a biopharmaceutical company focused on the development of targeted therapeutics for the treatment of inflammatory diseases and cancer, announced a major corporate restructuring with the objective of prioritizing and segregating its R&D efforts on a focused set of products in inflammatory disease and dermatology and strengthening its financial position. 

[Read More]